---
title: "Shanghai Xuerong Biotechnology Co.,Ltd. (300511.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300511.SZ.md"
symbol: "300511.SZ"
name: "Shanghai Xuerong Biotechnology Co.,Ltd."
industry: "Agricultural Products and Services"
datetime: "2026-05-21T16:50:07.784Z"
locales:
  - [en](https://longbridge.com/en/quote/300511.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300511.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300511.SZ.md)
---

# Shanghai Xuerong Biotechnology Co.,Ltd. (300511.SZ)

## Company Overview

Shanghai Xuerong Biotechnology Co.,Ltd., together with its subsidiaries, engages in the research and development, cultivation and sale of fresh edible mushrooms in the People’s Republic of China. It offers enoki mushrooms; shiitake mushrooms, including oyster mushrooms, white jade mushrooms and seafood mushrooms; king oyster mushrooms; and velvet mushrooms, as well as Pleurotus eryngii and Flammulina velutipes. The company was formerly known as Shanghai Gaorong Food Co., Ltd. Shanghai Xuerong Biotechnology Co., Ltd.

| Item | Detail |
|------|--------|
| Industry | Agricultural Products and Services |
| Exchange | CN Market |
| Website | [www.xuerong.com](https://www.xuerong.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:13.000Z

**Overall: B (0.36)**

**Industry**: Agricultural Products and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 3 / 30 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 11.34% |  |
| Net Profit YoY | 131.82% |  |
| P/B Ratio | 2.50 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 4451720761.48 |  |
| Revenue | 2221565974.53 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 13.20% | B |
| Profit Margin | 8.79% | B |
| Gross Margin | 33.63% | C |
| Revenue YoY | 11.34% | B |
| Net Profit YoY | 131.82% | A |
| Total Assets YoY | 0.75% | C |
| Net Assets YoY | 57.52% | A |
| Cash Flow Margin | 272.51% | A |
| OCF YoY | 11.34% | B |
| Turnover | 0.60 | B |
| Gearing Ratio | 54.48% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Shanghai Xuerong Biotechnology Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "11.34%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "131.82%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.50",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "4451720761.48",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "2221565974.53",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "13.20%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "8.79%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "33.63%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "11.34%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "131.82%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "0.75%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "57.52%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "272.51%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "11.34%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.60",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "54.48%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 21.54 | 6/30 | 26.29 | 24.82 | 22.79 |
| PB | 2.36 | 16/30 | 3.20 | 2.98 | 2.78 |
| PS (TTM) | 1.89 | 18/30 | 2.45 | 2.17 | 1.93 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | KMCJNC (300505.SZ) | B | A | A | B | C | B |
| 02 | SHENNONG SEED (300189.SZ) | A | A | D | B | C | B |
| 03 | XUERONG (300511.SZ) | B | B | B | C | B | B |
| 04 | CHINAGREEN BIO (300970.SZ) | B | A | B | B | A | B |
| 05 | LONTRUE (300175.SZ) | D | B | C | A | A | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300511.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300511.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300511.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300511.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**